Cart
sales@molnova.com
FLT3-IN-10
CAS No. 2088735-51-5
FLT3-IN-10( 2-Oxazolamine, 5-(4-fluorophenyl)-N-phenyl-5-(4-fluorophenyl)-N-phenyl-1,3-oxazol-2-amine )
Catalog No. M28938 CAS No. 2088735-51-5
FLT3-IN-10 (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 115 | Get Quote |
|
| 10MG | 200 | Get Quote |
|
| 25MG | 410 | Get Quote |
|
| 50MG | 605 | Get Quote |
|
| 100MG | 860 | Get Quote |
|
| 500MG | 1728 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameFLT3-IN-10
-
NoteResearch use only, not for human use.
-
Brief DescriptionFLT3-IN-10 (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML).
-
DescriptionFLT3-IN-10 (compound 7c) is a potent inhibitor of FMS-like tyrosine kinase 3 (FLT3). FLT3-IN-10 shows the potential for the treatment of FLT3-mutated acute myeloid leukemia (AML).
-
In Vitro——
-
In Vivo——
-
Synonyms2-Oxazolamine, 5-(4-fluorophenyl)-N-phenyl-5-(4-fluorophenyl)-N-phenyl-1,3-oxazol-2-amine
-
PathwayAngiogenesis
-
TargetFLT
-
Recptorneuropeptide Y (NPY) Y1 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2088735-51-5
-
Formula Weight254.26
-
Molecular FormulaC15H11FN2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (491.62 mM)
-
SMILESFC=1C=CC(=CC1)C=2OC(=NC2)NC=3C=CC=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Antal-Zimanyi I, et al. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist. Eur J Pharmacol. 2008 Aug 20;590(1-3):224-32.
molnova catalog
related products
-
Emavusertib
Emavusertib is a potent IRAK4/FLT3 inhibtor. CA-4948 with anti-tumor activity.
-
TG-89
TG-89 is an inhibitor of JAK2, JAK3, RET and FLT3, and has an IC50 value of 11.2 μM against JAK2, showing anticancer activity in the treatment of ovarian and cervical cancer.
-
JAK3-IN-14
JAK3-IN-14 is a potent, selective and orally active FLT3 inhibitor, with IC50s of ～40, 8, and 4 nM for FLT3-WT, FLT3-D835Y, and FLT3-D835H, respectively.
